3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Endocrine
1
Conditions
Neoplasms
3
Warts
2
Keratosis, Actinic
2
Hyperthermia
2
Hematologic Neoplasms
2
Hemangioma
2
Squamous Intraepithelial Lesions
1
Skin Neoplasms
1
Sarcoma
1
Recurrence
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Polycystic Ovary Syndrome
1
Pituitary Neoplasms
1
Pelvic Neoplasms
1
Pain
1
Obesity
1
Nonmelanoma Skin Cancers
1
Mucositis
1
Metastatic Castration-resistant Prostate Cancer (mCRPC)
1
Melanoma
1
Kidney Neoplasms
1
Invasive Fungal Infections
1
Insulinoma
1
Infertility, Female
1
Infertility
1
Inappropriate Prescribing
1
Hyperinsulinism
1
Hemorrhage
1
Head and Neck Carcinoma
1
Interventions
Surgical Procedures, Operative
4
Cabergoline
4
Temozolomide
3
Propofol
3
Hydrocortisone
3
Dexmedetomidine
3
lanreotide
2
Sevoflurane
2
Saline Solution
2
Rosiglitazone
2
Radiotherapy
2
Radiosurgery
2
Proton Therapy
2
Human Growth Hormone
2
Desflurane
2
Aminolevulinic Acid
2
pasireotide
1
parecoxib
1
lutetium Lu 177 dotatate
1
loxoprofen
1
Yoga
1
Visual Field Tests
1
Visual Acuity
1
Trimethoprim
1
Transcranial Magnetic Stimulation
1
Tranexamic Acid
1
Tramadol
1
Surveys and Questionnaires
1
Supine Position
1
Sulfamethoxazole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Pituitary Neoplasms
×
Solutions
×
Clear all
NCT03439709
2018-03-01
MERGE
Samsung Medical Center
Phase 3
Unknown
90 enrolled